These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18207461)

  • 1. Effect of quality of gynaecological ultrasonography on management of patients with suspected ovarian cancer: a randomised controlled trial.
    Yazbek J; Raju SK; Ben-Nagi J; Holland TK; Hillaby K; Jurkovic D
    Lancet Oncol; 2008 Feb; 9(2):124-31. PubMed ID: 18207461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.
    Nunes N; Ambler G; Foo X; Widschwendter M; Jurkovic D
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):829-835. PubMed ID: 28976616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of ultrasound subjective 'pattern recognition' for the diagnosis of borderline ovarian tumors.
    Yazbek J; Raju KS; Ben-Nagi J; Holland T; Hillaby K; Jurkovic D
    Ultrasound Obstet Gynecol; 2007 May; 29(5):489-95. PubMed ID: 17444554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China.
    He P; Wang JJ; Duan W; Song C; Yang Y; Wu QQ
    J Ovarian Res; 2021 Dec; 14(1):169. PubMed ID: 34857005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
    Gilbert L; Basso O; Sampalis J; Karp I; Martins C; Feng J; Piedimonte S; Quintal L; Ramanakumar AV; Takefman J; Grigorie MS; Artho G; Krishnamurthy S;
    Lancet Oncol; 2012 Mar; 13(3):285-91. PubMed ID: 22257524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonography and computed tomography for management of adnexal masses in Iranian patients with suspected ovarian cancer: results of a prospective study.
    Behtash N; Rahmani M; Ghotbizadeh F; Karimi Zarchi M; Mousavi A
    Asian Pac J Cancer Prev; 2009; 10(2):201-4. PubMed ID: 19537883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial.
    Janda M; Gebski V; Brand A; Hogg R; Jobling TW; Land R; Manolitsas T; McCartney A; Nascimento M; Neesham D; Nicklin JL; Oehler MK; Otton G; Perrin L; Salfinger S; Hammond I; Leung Y; Walsh T; Sykes P; Ngan H; Garrett A; Laney M; Ng TY; Tam K; Chan K; Wrede CD; Pather S; Simcock B; Farrell R; Obermair A
    Lancet Oncol; 2010 Aug; 11(8):772-80. PubMed ID: 20638899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
    du Bois A; Kristensen G; Ray-Coquard I; Reuss A; Pignata S; Colombo N; Denison U; Vergote I; Del Campo JM; Ottevanger P; Heubner M; Minarik T; Sevin E; de Gregorio N; Bidziński M; Pfisterer J; Malander S; Hilpert F; Mirza MR; Scambia G; Meier W; Nicoletto MO; Bjørge L; Lortholary A; Sailer MO; Merger M; Harter P;
    Lancet Oncol; 2016 Jan; 17(1):78-89. PubMed ID: 26590673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis.
    Nunes N; Ambler G; Foo X; Naftalin J; Widschwendter M; Jurkovic D
    Ultrasound Obstet Gynecol; 2014 Nov; 44(5):503-14. PubMed ID: 24920435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficiency of ultrasonography in the diagnosis of dermoid cysts.
    Ekici E; Soysal M; Kara S; Dogan M; Gokmen O
    Zentralbl Gynakol; 1996; 118(3):136-41. PubMed ID: 8900602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
    Booth SJ; Turnbull LW; Poole DR; Richmond I
    BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
    Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
    Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Ann Surg Oncol; 2008 Jul; 15(7):2012-9. PubMed ID: 18437497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sonographic characterization, Doppler ultrasonography and tumor markers in the diagnosis of malignancy of ovarian masses].
    Gramellini D; Rutolo S; Verrotti C; Piantelli G; Fieni S; Vadora E
    Minerva Ginecol; 2001 Feb; 53(1):1-11. PubMed ID: 11279390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial.
    van der Pas MH; Haglind E; Cuesta MA; Fürst A; Lacy AM; Hop WC; Bonjer HJ;
    Lancet Oncol; 2013 Mar; 14(3):210-8. PubMed ID: 23395398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
    Coleman R; Cameron D; Dodwell D; Bell R; Wilson C; Rathbone E; Keane M; Gil M; Burkinshaw R; Grieve R; Barrett-Lee P; Ritchie D; Liversedge V; Hinsley S; Marshall H;
    Lancet Oncol; 2014 Aug; 15(9):997-1006. PubMed ID: 25035292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses.
    Sayasneh A; Kaijser J; Preisler J; Johnson S; Stalder C; Husicka R; Guha S; Naji O; Abdallah Y; Raslan F; Drought A; Smith AA; Fotopoulou C; Ghaem-Maghami S; Van Calster B; Timmerman D; Bourne T
    Gynecol Oncol; 2013 Jul; 130(1):140-6. PubMed ID: 23578539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Examination, treatment and follow-up of ovarian cancer in Norway].
    Paulsen T; Kjaerheim K; Kaern J; Norstein J; Onsrud M
    Tidsskr Nor Laegeforen; 2001 Sep; 121(23):2696-700. PubMed ID: 11699376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of ovarian mass and diagnostic performance of ultrasonography pattern recognition among women at the Gynaecologic Ultrasonography Unit at University Hospital in Thailand.
    Panichyawat N; Tanmahasamut P; Jaishuen A; Asumpinwong C; Chantrapanichkul P
    J Obstet Gynaecol; 2022 Aug; 42(6):2260-2264. PubMed ID: 35275042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.